BATM

Company Overview

Snapshot

Founded in January 1992 by Zvi Marom, BATM operates with 51–200 employees. The company has raised a total of $18 million across two funding rounds. A significant milestone for BATM was its initial public offering on the London Stock Exchange in July 1999.

Business overview

BATM develops real-time technologies for networking, cyber-security, and biomedical and biowaste treatment solutions through its two primary divisions. The biomedical division focuses on diagnostic laboratory equipment and services, alongside products for treating biological pathogenic waste in medical, agricultural, and pharmaceutical industries. Concurrently, its networking and cyber division delivers telecommunication network solutions, emphasizing advanced software and cyber security for tier-one businesses and governments globally. The company operates across sectors including Cyber Security and Health Tech & Life Sciences.

Strategic signal

In October 2023, BATM invested US$3.5 million in diagnostics business ADOR. This strategic investment signals BATM's continued commitment to expanding its biomedical division and enhancing its capabilities in the diagnostics market, indicating a focus on growth through targeted acquisitions and investments in key technological areas.

Company Intelligence Q&A

When did BATM go public?

BATM completed its Initial Public Offering on the London Stock Exchange in July 1999.

What was a recent strategic investment by BATM?

In October 2023, BATM invested US$3.5 million in the diagnostics business ADOR, expanding its presence in the medical diagnostics sector.

Has BATM secured any recent cyber security contracts?

In October 2023, BATM secured a multimillion-dollar cyber security order. This followed another cyber security contract win with a government defense department in September 2023.

Who was the lead investor in BATM's June 2019 funding round?

In June 2019, BATM raised $18 million in a funding round, with Shore Capital acting as the sole bookrunner.

What was a notable acquisition made by BATM in the biomedical sector?

In February 2017, BATM acquired Zer Laboratories, expanding its medical diagnostic business.